Detailed Overview of the Neurodegenerative Disease Market Including Therapeutics, Diagnostics, and Medical Devices for Alzheimer's, Parkinson's, ALS, Huntington's, and Multiple Sclerosis

Neurodegenerative Disease Market Size and Forecast

The Neurodegenerative Disease Market is expected to grow at a CAGR of 7.45% during the forecast period 2024-2031

The Neurodegenerative Disease Market refers to the global industry focused on the research, development, manufacturing, and commercialization of therapies, drugs, diagnostics, and medical devices used to treat or manage neurodegenerative diseases. These diseases involve the progressive degeneration of nerve cells, affecting the nervous system and leading to cognitive, motor, and functional impairments. Key conditions in this market include Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis. Market growth is driven by rising prevalence of these disorders, an aging population, advancements in drug development, and increased healthcare awareness.

DataM Intelligence has published a new research report on "Neurodegenerative Disease Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neurodegenerative-disease-market?rk

Recent Developments:

🧠 1. Cutting‐Edge Scientific Discoveries

🔬 Novel Biological Targets & Therapeutics
Researchers identified a hidden molecular "death switch" in the brain involving NMDA receptors and TRPM4 channels linked to neuron death. A compound called FP802 can block this toxic interaction and showed promising results in mouse models of Alzheimer's indicating a potential new therapeutic direction beyond traditional amyloid‐targeting strategies.

🧪 2. Clinical Pipeline Updates
📈 Phase III and Trials Activity
Annovis Bio highlighted clinical updates, including data on buntanetap in Phase III trials for early Alzheimer's and Parkinson's disease, focusing on cognition and biomarkers.

📉 3. Market Growth & Forecast Trends

📊 Market Size & Innovation
The neurodegenerative disease market is projected to rise significantly over the next decade, driven by aging populations, strong demand for disease-modifying drugs, and improved diagnostic tools.

📈 Biologics & Gene/RNA‐based Therapies
Gene and RNA therapies are expected to grow fastest within the market, with biotechnology firms pushing these modalities into late-stage development, reshaping competitive dynamics.

🧬 4. Strategic Research Collaborations

🤝 Precision Medicine & Parkinson's
Major pharmaceutical firms have initiated partnerships to accelerate precision medicine development for Parkinson's disease, using advanced genetic and biomarker insights to tailor therapies.

🤖 AI & Digital Tools
Artificial intelligence, machine learning partnerships, and smart diagnostic platforms are increasingly integrated into clinical research and diagnostics to speed up target discovery and improve early detection.

🧪 5. Diagnostics & Biomarker Advances

🔍 Diagnostics Market Expansion
The neurological diagnostics market is forecast to grow, boosting imaging diagnostics and biomarker assays (e.g., amyloid, tau, α‐synuclein), with AI-assisted solutions improving early diagnosis and monitoring.

📊 Experimental Diagnostic Tech
Academic research includes advanced machine learning models and biosensors to enhance early detection and personalized disease progression models.

🏛️ 6. Regulatory & Commercial Challenges

🚫 Gene Therapy Setbacks
Recent setbacks in Huntington's disease gene therapy highlight the regulatory challenges and high risk in this area, prompting firms to adjust their clinical trial strategies.

📉 7. Broader Scientific & Public Health Trends
🧬 Genetic Insights
Discoveries like a gene mutation that significantly delays Alzheimer's onset provide new biological understanding that could inspire novel therapeutic strategies.

👥 Research Culture
Calls for more collaborative, interdisciplinary research in Parkinson's and other neurodegenerative disorders aim to accelerate innovation.

Key Players:

AbbVie Inc., Amneal Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical, UCB SA, Novartis.

Growth Forecast Projected:

The Global Neurodegenerative Disease Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Neurodegenerative Disease Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=neurodegenerative-disease-market?rk

Key Segments:

By Indication Type: Parkinson's Disease, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Huntington Disease, Others.

By Drug Type: N-methyl-D-aspartate Receptor, Selective Serotonin Reuptake Inhibitor, the Dopamine Inhibitors, Others.

By End-User: Hospitals, Clinics, Others.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neurodegenerative-disease-market?rk

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.